High-grade glioma in elderly patients: can the oncogeriatrician help?

Emeline Tabouret,1 Louis Tassy,2 Olivier Chinot,1 ElodieCrétel,3 Frederique Retornaz,4 Frederique Rousseau5 1Department of Neuro-oncology, Timone Hospital, Marseille, France; 2Department of Medical Oncology, Centre Léon Bérard, Lyon, France; 3Transveral Oncogeriatric...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tabouret E, Tassy L, Chinot O, Crétel E, Retornaz F, Rousseau F
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/79a63ad12ea7411f99c295d6d9f55052
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:79a63ad12ea7411f99c295d6d9f55052
record_format dspace
spelling oai:doaj.org-article:79a63ad12ea7411f99c295d6d9f550522021-12-02T07:35:31ZHigh-grade glioma in elderly patients: can the oncogeriatrician help?1178-1998https://doaj.org/article/79a63ad12ea7411f99c295d6d9f550522013-12-01T00:00:00Zhttps://www.dovepress.com/high-grade-glioma-in-elderly-patients-can-the-oncogeriatrician-help-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Emeline Tabouret,1 Louis Tassy,2 Olivier Chinot,1 ElodieCrétel,3 Frederique Retornaz,4 Frederique Rousseau5 1Department of Neuro-oncology, Timone Hospital, Marseille, France; 2Department of Medical Oncology, Centre Léon Bérard, Lyon, France; 3Transveral Oncogeriatric Unit, University Hospital Timone, Marseille, France; 4Departmental Gerontologic Center, Marseille, France; 5Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France Abstract: Gliomas are the most frequent primary brain tumors in adults. As the population ages in Western countries, the number of people being diagnosed with glioblastoma is expected to increase. Clinical management of elderly patients with primary brain tumors is difficult, owing to multiple comorbidities, polypharmacy, decreased tolerance to chemotherapy, and an increased risk of radiation-induced neurotoxicity. A few specific randomized studies have shown a benefit for radiotherapy in elderly patients with good performance status. For patients with poor performance status, chemotherapy (temozolomide) has been shown to be associated with prolonged duration of response. Patients with methylated O6-alkylguanine deoxyribonucleic acid alkyltransferase promoter seem to have better outcomes. Oncogeriatrics proposes the geriatric evaluation of elderly patients to improve therapeutic choices and optimize the management of treatment toxicities and comorbidities. Keywords: brain tumor, older cancer patient, chemotherapy toxicity, oncogeriatric charterTabouret ETassy LChinot OCrétel ERetornaz FRousseau FDove Medical Pressarticlebrain tumorolder cancer patientchemotherapy toxicityoncogeriatric charterGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 8, Pp 1617-1624 (2013)
institution DOAJ
collection DOAJ
language EN
topic brain tumor
older cancer patient
chemotherapy toxicity
oncogeriatric charter
Geriatrics
RC952-954.6
spellingShingle brain tumor
older cancer patient
chemotherapy toxicity
oncogeriatric charter
Geriatrics
RC952-954.6
Tabouret E
Tassy L
Chinot O
Crétel E
Retornaz F
Rousseau F
High-grade glioma in elderly patients: can the oncogeriatrician help?
description Emeline Tabouret,1 Louis Tassy,2 Olivier Chinot,1 ElodieCrétel,3 Frederique Retornaz,4 Frederique Rousseau5 1Department of Neuro-oncology, Timone Hospital, Marseille, France; 2Department of Medical Oncology, Centre Léon Bérard, Lyon, France; 3Transveral Oncogeriatric Unit, University Hospital Timone, Marseille, France; 4Departmental Gerontologic Center, Marseille, France; 5Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France Abstract: Gliomas are the most frequent primary brain tumors in adults. As the population ages in Western countries, the number of people being diagnosed with glioblastoma is expected to increase. Clinical management of elderly patients with primary brain tumors is difficult, owing to multiple comorbidities, polypharmacy, decreased tolerance to chemotherapy, and an increased risk of radiation-induced neurotoxicity. A few specific randomized studies have shown a benefit for radiotherapy in elderly patients with good performance status. For patients with poor performance status, chemotherapy (temozolomide) has been shown to be associated with prolonged duration of response. Patients with methylated O6-alkylguanine deoxyribonucleic acid alkyltransferase promoter seem to have better outcomes. Oncogeriatrics proposes the geriatric evaluation of elderly patients to improve therapeutic choices and optimize the management of treatment toxicities and comorbidities. Keywords: brain tumor, older cancer patient, chemotherapy toxicity, oncogeriatric charter
format article
author Tabouret E
Tassy L
Chinot O
Crétel E
Retornaz F
Rousseau F
author_facet Tabouret E
Tassy L
Chinot O
Crétel E
Retornaz F
Rousseau F
author_sort Tabouret E
title High-grade glioma in elderly patients: can the oncogeriatrician help?
title_short High-grade glioma in elderly patients: can the oncogeriatrician help?
title_full High-grade glioma in elderly patients: can the oncogeriatrician help?
title_fullStr High-grade glioma in elderly patients: can the oncogeriatrician help?
title_full_unstemmed High-grade glioma in elderly patients: can the oncogeriatrician help?
title_sort high-grade glioma in elderly patients: can the oncogeriatrician help?
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/79a63ad12ea7411f99c295d6d9f55052
work_keys_str_mv AT tabourete highgradegliomainelderlypatientscantheoncogeriatricianhelp
AT tassyl highgradegliomainelderlypatientscantheoncogeriatricianhelp
AT chinoto highgradegliomainelderlypatientscantheoncogeriatricianhelp
AT creacutetele highgradegliomainelderlypatientscantheoncogeriatricianhelp
AT retornazf highgradegliomainelderlypatientscantheoncogeriatricianhelp
AT rousseauf highgradegliomainelderlypatientscantheoncogeriatricianhelp
_version_ 1718399345928175616